Only two randomized controlled trials (RCTs) with GLP-1RAs in the context of alcohol use have been published so far
Pictures need to be clear, well lit, and have the same angle on every visit so you can see progression
GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management
Otherwise, the new GLP-1 medications may be a better choice since you can stop the medication. Do people need to focus on nutrition while taking weight-loss drugs
Were now seeing bad actors use the compounding label to mass-produce and market GLP-1 drugs that havent undergone the safety testing required of FDA-approved products
Inflammatory Response Tissue injury from liposuction releases cytokines, prostaglandins, and other proinflammatory molecules